Paul F. Reid
Keine laufenden Positionen mehr
Karriereverlauf von Paul F. Reid
Ehemalige bekannte Positionen von Paul F. Reid
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NUTRA PHARMA CORP. | Direktor/Vorstandsmitglied | 10.04.2008 | 18.11.2009 |
Präsident | - | 18.11.2009 | |
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Corporate Officer/Principal | 01.01.1993 | 01.01.1993 |
ReceptoPharm, Inc.
ReceptoPharm, Inc. Pharmaceuticals: MajorHealth Technology ReceptoPharm, Inc. develops proprietary therapeutic protein products for the prevention and treatment of viral and neurological diseases. It provides benefits for patients with such diseases as acquired immunodeficiency syndrome, multiple sclerosis, myasthenia gravis, and other viral disorders. The company was founded on June 4, 2001 and is headquartered in Plantation, FL. | Vorstandsvorsitzender | 04.06.2001 | - |
Gründer | 18.11.2009 | - |
Ausbildung von Paul F. Reid
Trinity College Dublin | Undergraduate Degree |
Imperial College London | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Irland | 2 |
Vereinigtes Königreich | 2 |
Operativ
Chief Executive Officer | 1 |
Founder | 1 |
Director/Board Member | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NUTRA PHARMA CORP. | Retail Trade |
Private Unternehmen | 2 |
---|---|
ReceptoPharm, Inc.
ReceptoPharm, Inc. Pharmaceuticals: MajorHealth Technology ReceptoPharm, Inc. develops proprietary therapeutic protein products for the prevention and treatment of viral and neurological diseases. It provides benefits for patients with such diseases as acquired immunodeficiency syndrome, multiple sclerosis, myasthenia gravis, and other viral disorders. The company was founded on June 4, 2001 and is headquartered in Plantation, FL. | Health Technology |
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Health Technology |
- Börse
- Insiders
- Paul F. Reid
- Erfahrung